Pascal Soriot, AstraZeneca CEO (Raphael Lafargue/Abaca/Sipa USA; Sipa via AP Images)
UK begins inquiry into AstraZeneca's $39B buyout of Alexion
The UK’s Competition and Markets Authority opened an inquiry on Tuesday into AstraZeneca’s proposed $39 billion acquisition of Alexion.
By July 21, the CMA …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
